Story · Medicine & Biotech
Key immune driver of pancreatic cancer points to combination treatment for slowing progression
1 outlet · first reported by Medical Xpress on
Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer. (Medical Xpress)
Coverage, in order
-
Key immune driver of pancreatic cancer points to combination treatment for slowing progressionResearchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.